Top section
Top section
High yields and tight senior/sub spread fuel enthusiasm for issuance among investors and issuers
◆ Pair help market to end week on a high note ◆ GSK offers pick-up over peer AstraZeneca ◆ Glencore finds demand at eight years
◆ French borrower takes €1.15bn across two tranches ◆ Balance struck between size and price to keep investors onside ◆ Small concession offered
Data
More articles
More articles
More articles
-
The subordinated debt premium was smaller than that offered by some other EM hybrid issuers -
At London investor day, supranational reveals deals and plans for new funding and investments, including fully African project financing
-
Bot claims funding is ‘cheaper than peers who borrow from independent banks or credit funds’
-
Third Canadian province to come to the currency this year
-
Investors maintain orders as issuers push tight, although some limits are appearing
-
Issuer’s second deal followed upward revision to Ebitda guidance
Sub-sections
